TrialClinical and vaccine immunology : CVI2014

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.

Maikel V W van der Velden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.